Publications
CIRS publishes insights from its research and meetings in several forms:
- R&D Briefings – research papers produced by the CIRS team e.g. annual regulatory and HTA benchmarking briefings
- Journal articles – peer reviewed academic research papers
- Reports – from CIRS workshops and externally commissioned research projects, as well as CIRS Annual Reports
- Books – research theses from CIRS-supported PhD students
- Posters – presented at external conferences
Keep up-to-date with CIRS publications and activities by signing up to our mailing list or following CIRS on LinkedIn.
2002 Workshop report – Risk management: Effective stakeholder communication during development
Risk management workshop: Identifying and developing effective stakeholder communication during drug development 12-13th December 2002, Washington DC, USA “Risk is complex and in managing it we must be aware of …
CIRS RD Briefing 37 – Adoption of ICH E5 in Asia Pacific
In 2001, CMR International conducted a study among pharmaceutical companies to evaluate their experience with regulatory authorities in Asia Pacific regarding the acceptance of foreign clinical data and adoption of …
CIRS RD Briefing 36 – Impact of ICH E5 guideline
The ICH E5 Guideline was introduced in February 1998 and subsequently implemented by the regulatory authorities of the USA, EU and Japan. The purpose of this guideline is to facilitate …
2002 Workshop report – Risk management: Role of regulatory strategies in development
Risk management: The role of regulatory strategies in the development of new medicines 25-26th April 2002, Surrey, UK The primary objective of the meeting was to develop a global perspective …
CIRS RD Briefing 31 – Regulatory review times
CMR International R&D Briefing 31 – Profile of performance: Review times – is there still room for improvement? Key messages: Performance improvement initiatives established by regulatory authorities in the early …